[1]
Hradyk Т. and Tsysnetska А., “The Role of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in the Treatment of Heart Failure in Patients with Type 2 Diabetes Mellitus”, APMPLMI, vol. 3, no. 1, pp. 1–10, May 2022.